KNSA
Kiniksa Pharmaceuticals Ltd
NASDAQ: KNSA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$52.99
-1.60% today
Updated 2026-04-29
Market cap
$4.08B
P/E ratio
58.23
P/S ratio
6.02x
EPS (TTM)
$0.91
Dividend yield
—
52W range
$25 – $54
Volume
0.8M
Kiniksa Pharmaceuticals Ltd (KNSA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-29.6%
Last 4 quarters
Revenue YoY growth
+65.0%
Most recent quarter
EPS YoY growth
+241.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.0%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+11.2%
2025-07-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $0.17 | -51.0% | $46.00 | $47.27 | +2.8% |
| 2025-10-28 | $0.23 | -27.4% | $40.60 | $37.38 | -7.9% |
| 2025-07-29 | $0.23 | +21.1% | $27.04 | $30.06 | +11.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.35 | $0.17 | -51.0% | $202.13M | +65.0% |
| 2025-09-30 | $0.32 | $0.23 | -27.4% | $180.85M | +61.2% |
| 2025-06-30 | $0.19 | $0.23 | +21.1% | $156.80M | +44.3% |
| 2025-03-31 | $0.28 | $0.11 | -61.2% | $137.78M | +72.5% |
| 2024-12-31 | $0.02 | $-0.12 | -700.0% | $122.54M | +46.9% |
| 2024-09-30 | $0.01 | $-0.18 | -1900.0% | $112.21M | +67.4% |
| 2024-06-30 | $-0.07 | $-0.06 | +14.3% | $108.63M | +52.0% |
| 2024-03-31 | $-0.16 | $-0.25 | -56.3% | $79.86M | — |
| 2023-12-31 | $-0.14 | $0.35 | +350.0% | $83.39M | — |
| 2023-09-30 | $-0.17 | $-0.20 | -17.6% | $67.05M | — |
| 2023-06-30 | $-0.17 | $0.21 | +223.5% | $71.47M | — |
Frequently asked questions
Has Kiniksa Pharmaceuticals Ltd beaten earnings estimates?
Kiniksa Pharmaceuticals Ltd has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -29.6% over the last 4 quarters.
How does KNSA stock react to earnings?
KNSA stock has moved an average of +2.0% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Kiniksa Pharmaceuticals Ltd's revenue growth rate?
Kiniksa Pharmaceuticals Ltd reported year-over-year revenue growth of +65.0% in its most recent quarter, with EPS growing +241.7% year-over-year.